Corporate News Report – Alcidion (ALC.AX)

Alcidion Group Ltd. (ALC.AX) closed the trading session on Wednesday, 21 November 2026, at 11:50 PM Central Europe with a 1.05 % increase over the previous close. The stock is currently trading at approximately AUD 0.10 on major Australian exchanges.

Market Overview

ItemValue
Current priceAUD 0.10
Supply of shares1.30 billion
Market capitalisationAUD 127.6 million
24‑hour trading volumeAUD 58.8 k
Price change since last month‑end–4 %
200‑day simple moving averageAUD 0.10
52‑week highAUD 0.14 (15 January 2026)
52‑week lowAUD 0.08 (27 July 2026)
CompanySymbol24‑hour changeCurrent priceMarket capitalisationPE ratio
Vita Life SciencesVLS.AX+0.72 %AUD 2.79AUD 149.8 million14.17
Strickland MetalsSTK.AX–1.79 %AUD 0.05AUD 147.9 million62.14
Torque MetalsTOR.AX–2.63 %AUD 0.18AUD 143.7 million–
Austral AustraliaAR1.AX0.00 %AUD 0.06AUD 147.2 million5.99
ReadytechRDY.AX+0.42 %AUD 1.25AUD 147.7 million–

Vita Life Sciences Buy‑back Update

Vita Life Sciences Limited announced a daily buy‑back of ordinary shares, initiated on 1 June 2026 and scheduled to continue until 27 May 2027. On 20 October 2026, approximately 478,000 shares were repurchased through Shaw and Partners, following a prior purchase of 100,000 shares on 19 October 2026. The repurchase price ranged from AUD 2.42 to AUD 2.78. No shareholder approval was required, and no additional details on total proceeds or maximum share purchase cap were disclosed.

Company Profile – Alcidion Group Ltd.

Alcidion Group Ltd. operates in the health technology sector across Australia and the United States. The company develops clinical decision support solutions that integrate clinical informatics technology to enhance patient care by providing clinicians with advanced decision‑making tools.